Tags: biopharmaceuticalRemove, solar powerRemove

The decline comes after the Chinese bio-pharmaceutical firm prices its IPO above the range. Fellow Nasdaq newcomer JA Solar trades up.
By Anette Jönsson | 8 February 2007
1
Tag Filters
Magazine
FinanceAsia Magazine
FinanceAsia
December 2011/January 2012